Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

... effusion, pulmonary edema, and ascites) and superficial edema (1.3%-11%), hemorrhage (1.8%-19%), and ... (e.g., pleural effusion or ascites; 3%; 8%) and superficial edema (6%; 5%), hemorrhage (6%; 11%), abdominal ... reported adverse reactions (all Grades) were superficial edema (60%-74%), nausea (50%-73%), muscle ...

Lorus initiates development program exploring novel route of administration for LOR-2040

... clinical-stage drug LOR-2040 for the treatment of superficial bladder cancer. The new development program ... the bladder) agents in treating locally confined, superficial bladder tumors. In fact intravesical ... for many approved chemotherapy drugs to treat superficial bladder cancer. "I am pleased that we have ...

IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors

... a Performance Goal Derived from Balloon Angioplasty Clinical Trials in the superficial Femoral Artery) IDE study. IDEV's SUPERA stent is a novel platform designed for the treatment of biliary and peripheral artery disease in the superficial femoral artery. "Tom was instrumental in building the foundation of ...

Reliant Technologies Announces FDA 510(K) Clearance of New Handpieces for Skin Resurfacing and Surgical Applications

... For skin resurfacing, the new Fraxel re:pair 600 micron handpiece performs superficial procedures both on and off-the face, including the neck, hands and chest, ... on the face, neck, chest and hands. The Fraxel re:fine laser, offering superficial non-invasive skin rejuvenation, combines the unique method of fractional ...

Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing

... (AFR(TM)) treatment. The Fraxel re:pair laser delivers treatment for superficial photodamage, including pigmentation, fine lines, texture and vascular ... on the face, neck, chest and hands. The Fraxel re:fine laser, offering superficial non-invasive skin rejuvenation, combines the unique method of fractional ...

Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia

... fluid retention (eg, pleural effusion, pulmonary edema, and ascites) and superficial edema (1.3%-11%), hemorrhage (1.8%-19%), and musculoskeletal pain (2%-9%) ... severity. The most frequently reported adverse reactions (all Grades) were superficial edema (60%-74%), nausea (50%-73%), muscle cramps (28%-62%), vomiting ...

Halozyme Therapeutics Reports 2007 Third Quarter Financial Results

... in its Chemophase(R) Phase I/IIa clinical trial for the treatment of superficial bladder cancer. Chemophase is a novel recombinant investigational ... with the widely used anticancer drug mitomycin in 27 patients with superficial bladder cancer. Interim data from this ongoing trial is expected ...

BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device

... assessment of tissue repair. Other statistically significant improvements were found in the assessments of Cell Morphology, Cell Viability and superficial Zone morphology in the biopsies. Furthermore, Surface Architecture, collagen structure as observed by Polarized Light Microscopy, and repair tissue ...

Cynosure Launches New Workstation and Technology Innovations at American Academy of Dermatology Annual Meeting

... MPX system. As a result, thermal energy is delivered to a targeted temperature setting, helping to ensure the safe and effective treatment of the superficial layer of the surface area. "Cynosure continues to enhance its Smartlipo technology with intelligent delivery systems that create a high level ...

Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors

... of solid tumors using photodynamic (light activation) therapy or sonodynamic (ultrasound activation) therapy. Photodynamic therapy is applicable for superficial level solid tumors and sonodynamic therapy targets more deeply seated solid tumors. "These results further define the therapeutic profile of ...

Wound Management Technologies, Inc. Announces a Published Case Study

... to: diabetic ulcers, venous stasis ulcers, ulcers due to arterial insufficiency, pressure ulcers stages I-IV, surgical wounds, traumatic wounds, superficial wounds, and 1st and 2nd degree burns. It comes in two forms, a powder which is about 95% collagen, and a gel which is about 65% collagen, and ...

Pilot Study Finds Adding Topical Imiquimod To Laser Therapy Improves The Response Of Port Wine Stain Birthmarks

... is a topical immune response modifier agent that is approved by the U.S. Food and Drug Administration (FDA) for the treatment of actinic keratoses, superficial basal cell carcinomas and genital warts. Imiquimod is also known to have anti-angiogenic (inhibits the growth of new blood vessels) properties which ...

Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting

... of the test articles into the operated knee joint. Cartilage regeneration was evaluated after three and six months. In another study, a more superficial knee cartilage defect that did not reach the bone was treated with four weekly intra-articular injections of AC-100 or placebo. In half of the goats ...

Halozyme Therapeutics Reports 2008 Second Quarter Financial Results

... compared to Humalog alone. -- Release of Chemophase(R) Phase I/IIa clinical results from a continuing clinical trial in the treatment of superficial bladder cancer. Based on the results, the Chemophase combination treatment of mitomycin plus the rHuPH20 enzyme was well tolerated and ...

Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008

... - Commenced a development program aimed at expanding the therapeutic application of its clinical-stage drug LOR-2040 for the treatment of superficial bladder cancer. - Completed a corporate reorganization resulting in approximately $6.9 million in additional cash for Lorus without diluting ...

Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)

... distribution and sale in the U.S. and Europe. Quill(TM) SRS MONODERM(TM), which is made from a rapidly resorbing polymer, is intended primarily for superficial wound closure applications and indicated for soft tissue approximation where use of an absorbable suture is appropriate. "The launch of ...

ZARS Pharma Announces Marketing Authorization of Rapydan(R) in Europe

... skin to provide surface anesthesia of the skin in connection with needle punctures, in children from 3 years and above, and needle punctures and superficial surgical procedures in adults. Rapydan resembles a small adhesive bandage in appearance and is similar in its ease of application. The patch is ...

Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line

... approximation," added Mr. Dennis. Quill(TM) SRS MONODERM(TM) sutures, which are made from a rapidly resorbing polymer, are intended primarily for superficial wound closure applications and indicated for soft tissue approximation where use of an absorbable suture is appropriate. It is anticipated that the ...

Talent Constellations or Talent Communities Choosing the Right Talent

... and rival camps and cultures competing for attention and resources. At worst, performance-sapping contradictions and conflicts wreak havoc beneath a superficial guise of balance. As Jeffrey Pfeffer of the Standford Business School has pointed out, There is not a shortage of good talent, but a shortage of ...

A social event for technology entrepreneurs

... knows your name. In addition to learning everyones name, were going to provide an opportunity for everyone in attendance to develop at least a superficial understanding of what the other attendees are working on. Our first speaker will be MCW professor and Prodesse, Inc., founder Dr. Kelly ...

Creating thousands of jobs, Chicagos biotech space to triple

... street, a lot of good memories of people I knew when working there came flooding back. As we wandered around the main building, I could see that some superficial modernizing already took place. As we exited the main building on the side, a new and architecturally striking building confronted me: the infamous ...

Making RFID mainstream

... simplicity of identification from a distance without the line-of-sight requirements of barcodes opens up a dizzying array of applications, yet that superficial simplicity belies an underlying complexity that arises in large part from the nature of RF wave propagation itself: absorption, reflection and ...

Praise for the principles of Peter

... be reasonably argued that Drucker had a greater impact on the practice of management than any other academic, yet ironically his work was seen as too superficial and not rigorous enough by many management scholars! According to James OToole of USC, Peter would never have gotten tenure in a major business ...

H-1B jobs: Where is the shortage of skilled workers?

... today's problems. Similar to the desperation tactics of a junkie, grab H-1B employees when needing his next fix. This is not a band-aid covering a superficial wound. This is more like taking two aspirin for someone with blunt head trauma. Again, we need to wake up. Our ability to compete in the future ...

Near Infrared Technology and Optical Agents For Molecular Imaging

... 700 nm, tissue absorption results in small penetration depths of only a few millimeters 1 . Thus in the visible region of the spectrum, only superficial assessment of tissue features is possible. The light absorption is due to oxy- and deoxyhemoglobin, melanin, lipid, and other compounds ...